Xavier Avat is currently the EVP and Chief Business Officer at Moffitt Cancer Center, where they lead strategic initiatives and business development. With extensive experience across Biopharma, Medtech, and Diagnostics, Xavier has successfully developed and launched multiple products and initiatives, notably growing sales significantly during their tenure at Gilead Sciences and Santen Pharmaceutical. They previously held leadership positions at companies like Merck, Genentech, and Edwards Lifesciences, focusing on strategic planning and portfolio management. Xavier's educational background includes engineering studies and an MBA, and they are actively involved in various board roles and ventures within the healthcare sector.
This person is not in the org chart
This person is not in any teams
This person is not in any offices